These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 24354814)

  • 1. Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles.
    Toy R; Peiris PM; Ghaghada KB; Karathanasis E
    Nanomedicine (Lond); 2014 Jan; 9(1):121-34. PubMed ID: 24354814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles.
    Jiang W; Huang Y; An Y; Kim BY
    ACS Nano; 2015 Sep; 9(9):8689-96. PubMed ID: 26212564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
    Overchuk M; Zheng G
    Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shape-specific polymeric nanomedicine: emerging opportunities and challenges.
    Tao L; Hu W; Liu Y; Huang G; Sumer BD; Gao J
    Exp Biol Med (Maywood); 2011 Jan; 236(1):20-9. PubMed ID: 21239732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of nanoparticle shape in cancer drug delivery.
    Truong NP; Whittaker MR; Mak CW; Davis TP
    Expert Opin Drug Deliv; 2015 Jan; 12(1):129-42. PubMed ID: 25138827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Form Follows Function: Nanoparticle Shape and Its Implications for Nanomedicine.
    Kinnear C; Moore TL; Rodriguez-Lorenzo L; Rothen-Rutishauser B; Petri-Fink A
    Chem Rev; 2017 Sep; 117(17):11476-11521. PubMed ID: 28862437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling particle shape-dependent dynamics in nanomedicine.
    Shah S; Liu Y; Hu W; Gao J
    J Nanosci Nanotechnol; 2011 Feb; 11(2):919-28. PubMed ID: 21399713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRINT: a novel platform toward shape and size specific nanoparticle theranostics.
    Perry JL; Herlihy KP; Napier ME; Desimone JM
    Acc Chem Res; 2011 Oct; 44(10):990-8. PubMed ID: 21809808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More effective nanomedicines through particle design.
    Wang J; Byrne JD; Napier ME; DeSimone JM
    Small; 2011 Jul; 7(14):1919-31. PubMed ID: 21695781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical nanomedicine.
    Rzigalinski BA; Meehan K; Davis RM; Xu Y; Miles WC; Cohen CA
    Nanomedicine (Lond); 2006 Dec; 1(4):399-412. PubMed ID: 17716143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuning the size, shape and structure of RNA nanoparticles for favorable cancer targeting and immunostimulation.
    Guo S; Xu C; Yin H; Hill J; Pi F; Guo P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1582. PubMed ID: 31456362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides as targeting elements and tissue penetration devices for nanoparticles.
    Ruoslahti E
    Adv Mater; 2012 Jul; 24(28):3747-56. PubMed ID: 22550056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nanotechnology for cancer imaging.
    Toy R; Bauer L; Hoimes C; Ghaghada KB; Karathanasis E
    Adv Drug Deliv Rev; 2014 Sep; 76():79-97. PubMed ID: 25116445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
    Liu J; Zhang R; Xu ZP
    Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications.
    Zarschler K; Rocks L; Licciardello N; Boselli L; Polo E; Garcia KP; De Cola L; Stephan H; Dawson KA
    Nanomedicine; 2016 Aug; 12(6):1663-701. PubMed ID: 27013135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy.
    Doane TL; Burda C
    Chem Soc Rev; 2012 Apr; 41(7):2885-911. PubMed ID: 22286540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in targeting strategies for nanoparticles in cancer imaging and therapy.
    Yhee JY; Lee S; Kim K
    Nanoscale; 2014 Nov; 6(22):13383-90. PubMed ID: 25273283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting nanoparticles to cancer.
    Wang M; Thanou M
    Pharmacol Res; 2010 Aug; 62(2):90-9. PubMed ID: 20380880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative nanoparticle tracking: applications to nanomedicine.
    Huang F; Dempsey C; Chona D; Suh J
    Nanomedicine (Lond); 2011 Jun; 6(4):693-700. PubMed ID: 21718178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in realizing selectivity for nanoparticle biodistribution and clearance: lessons from gold nanoparticles.
    Haute DV; Berlin JM
    Ther Deliv; 2017 Aug; 8(9):763-774. PubMed ID: 28825391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.